Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy

AI Briefing

• – Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy
• – Agreement enables selection of Kahimmune’s first companion neoantigen therapy candidate against colorectal and pancreatic cancer
• – Financial support from an undisclosed partner to accelerate development of the therapy